We are a mobile phone-based product, offering symptom management and smart interventions for complications arising from Diabetes and associated comorbidities. Diabetes is one of the diseases with profound complications, including heart disease, stroke, kidney failure, loss of limbs, and retinopathy. Diabetes affects 25.8 million people which is 8.3% of the U.S. population, costing us about $245 Billion. We are the first product to combine predictive modeling, machine learning and care practices to introduce interventions for Diabetes complications.
We drew inspiration from a study conducted by the University of Stirling, UK, which concluded that a mobile phone-based Advanced Symptom Management System (AsyMS) can support the management of symptoms in patients receiving chemotherapy for lung, breast, and colorectal cancer. More information on this study can be found at pubmed.gov under the link http://www.ncbi.nlm.nih.gov/pubmed/18953579.